Cargando…
Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
Schizophrenia is a severe mental disorder which leads to functional deterioration. Early detection and intervention are vital for better prognosis. However, the diagnosis of schizophrenia still depends on clinical observation to date. Without reliable biomarkers, schizophrenia is difficult to detect...
Autores principales: | Lin, Chieh-Hsin, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400883/ https://www.ncbi.nlm.nih.gov/pubmed/30873052 http://dx.doi.org/10.3389/fpsyt.2019.00093 |
Ejemplares similares
-
Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019) -
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018) -
Autism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy
por: Tzang, Ruu-Fen, et al.
Publicado: (2019) -
Astrocytic Regulation of Glutamate Transmission in Schizophrenia
por: Mei, Yu-Ying, et al.
Publicado: (2018) -
Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)